TIM-3 therapy represents a groundbreaking approach in the field of Alzheimer's disease treatment, leveraging immune checkpoint inhibitors to promote plaque clearance and enhance cognitive function.Recent studies have illuminated the critical role of TIM-3, a checkpoint molecule that hinders microglia— the brain's immune cells— from effectively attacking and removing amyloid plaques associated with Alzheimer's.